A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment by JoAnn Difede, Andrew A. McAleavey, Mariel Emrich, Adina Jick, Annell Ovalles, Katarzyna Wyka, Lisa Spielman, Megan Olden, Melissa Peskin, Colleen Becket-Davenport, Amy Rubenstein, Michael J. Brownstein, Eve Damiano, Debra Itzkowitz, Shi-fang Lu, Nancy J. Needell, James H. Kocsis, Janna S. Gordon-Elliott, Neal G. Simon

Get full text